Brief Description
Product name | Estradiol Cypionate |
Synonyms | Estradiol 17-Cypionate; estradiol 17-beta-cipionate; estradiol 17-beta-(3-cyclopentylpropionate); Oestradiol Cypionate; Estradiol Cypionate; 3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate; (17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate; (8xi,9xi,14xi,17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate; Depofemin |
MOQ | 25KG |
CAS No. | 313-06-4 |
Appearance | An almost white powder |
Molecular Formula | C26H36O3 |
Molecular Weight | 396.5622 |
Assay | 99% |
Application | Pharma grade or research purpose |
Packing | As per your request |
Storage | Preserve in tight, light-resistant containers in a cool place |
Remarks | NA |
Custom synthesis | Available |
Supply Ability | 10000kg/month |
Medical use
The medical uses of estradiol cypionate are the same as those of estradiol and other estrogens. Examples of indications for the drug include hormone therapy and hormonal contraception. In regard to the latter, estradiol cypionate has been used in combination with medroxyprogesterone acetate as a combined injectable contraceptive. Along with estradiol valerate, estradiol undecylate, and estradiol benzoate, estradiol cypionate is used as a form of high-dose estrogen therapy in feminizing hormone therapy for transgender women.
Estradiol cypionate is usually used at a dosage of 1 to 5 mg by intramuscular injection every 3 to 4 weeks in the treatment of menopausal symptoms such as hot flashes and vaginal atrophy, at a dosage of 1.5 to 2 mg by intramuscular injection once a month in the treatment of female hypoestrogenism due to hypogonadism, and at a dosage of 2 to 10 mg by intramuscular injection once every 1 or 2 weeks for hormone therapy in transgender women.
Our Factory: